BioCentury
ARTICLE | Finance

Hope springs eternal

August 10, 2009 7:00 AM UTC

In a turn of events that could hardly have been imagined even a couple of months ago, some biotech bankers, VCs and companies are prepping for the return of an IPO market.

The most optimistic anticipate new S-1 filings in the next few quarters from companies with revenue, approved products and/or extremely promising Phase III data for a candidate addressing large markets, with the window cracking open around the end of 2009 or the beginning of 2010...